Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Incorporation of Preservatives in Lyophilized Formulations

Posted on By

SOP for Incorporation of Preservatives in Lyophilized Formulations

Standard Operating Procedure for Incorporation of Preservatives in Lyophilized Formulations

1) Purpose

This SOP describes the process of incorporating preservatives into lyophilized formulations to ensure product stability and sterility during storage and usage.

2) Scope

This SOP applies to all personnel involved in the preparation of formulations that require preservatives for lyophilization, including formulation scientists and operators.

3) Responsibilities

  • Formulation Scientists: Responsible for selecting appropriate preservatives.
  • Operators: Responsible for incorporating the preservative according to the Batch Manufacturing Record (BMR).
  • QA: Responsible for verifying the preservative addition and documentation.
See also  SOP for Preparation of Nanoparticle-Based Lyophilized Formulations

4) Procedure

4.1 Selection of Preservatives

4.1.1 Criteria for Selection

  • 4.1.1.1 Preservatives must be non-toxic, effective in low concentrations, and compatible with the formulation and lyophilization process.
  • 4.1.1.2 Commonly used preservatives include benzyl alcohol, phenol, and parabens.

4.2 Incorporation of Preservatives

4.2.1 Weighing and Dispensing

  • 4.2.1.1 Weigh the preservative using a calibrated balance as specified in the BMR.
  • 4.2.1.2 Dispense the preservative into the solution while stirring gently to ensure uniform distribution.

4.2.2 Homogenization

  • 4.2.2.1 Mix the preservative with the formulation using a mechanical stirrer to ensure uniformity.

4.3 Documentation

All steps, including the preservative’s weight and batch number, must be recorded in the Preservative Addition Logbook and verified by QA.

See also  SOP for Packaging of Lyophilized Products

5) Abbreviations

  • BMR: Batch Manufacturing Record

6) Documents

  • Preservative Addition Logbook

7) References

  • Pharmacopoeial guidelines on preservatives
in pharmaceutical products

8) SOP Version

Version 1.0

Annexure

Preservative Addition Logbook Template

Date Preservative Name Batch No. Quantity Operator Initials QA Verification
DD/MM/YYYY Preservative Name Batch Number Quantity (grams) Operator Name QA Initials
           


Lyophilized Products Tags:Aseptic lyophilization process SOP, FDA guidelines for lyophilized products, Freeze-drying cycle development SOP, Lyophilized product SOP, Lyophilizer calibration SOP, Moisture content testing in lyophilized products, Pharmaceutical freeze-drying SOP, Quality control SOP for lyophilized drugs, SOP for cryoprotectants in lyophilized formulations, SOP for freeze-dried formulation optimization, SOP for handling lyophilized products, SOP for lyophilization of injectable drugs, SOP for lyophilization process in pharmaceuticals, SOP for lyophilization process validation, SOP for lyophilized antibiotics production, SOP for lyophilized product packaging, SOP for lyophilized product storage, SOP for lyophilized product vial filling, SOP for lyophilized vaccine production, SOP for lyophilizer equipment maintenance, SOP for pharmaceutical freeze-drying validation, SOP for primary drying in lyophilization, SOP for reconstitution of lyophilized drugs, SOP for secondary drying in lyophilization, SOP for stability testing of lyophilized products

Post navigation

Previous Post: Nanoparticle Formulation : SOP for Use of Cryoprotectants in Nanoparticle Formulations
Next Post: SOP for Use of Cholesterol in Liposome Formulations

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version